1000007839

Piramal Pharma Limited

157.81
-6.53 (-3.97%) tick NSE

Last updated on 20 Jan 2026 11:40 PM

Returns
-6.50%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

21819.61

Earning Per Share

-0.18

Dividend Yield

0.08%

P/E Ratio

-911.94

P/B Ratio

2.70

Debt to Equity

0.60

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India. In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Similar Companies